BioSpace News Archive

vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D), today reported financial results for the fourth quarter and year ended December 31, 2023, and provided an update on recent corporate developments.

Expert Systems, a leader in AI-enabled drug discovery, proudly announces a significant milestone in partnership with Eilean Therapeutics LLC: the start of Phase 1 trial of balamenib (ZE63-0302), a highly selective inhibitor of the menin–KMT2A binding interaction, under the Clinical Trial Notification (CTN) scheme of the Australian Therapeutics Goods Administration (TGA).

CalciMedica Inc. last evening presented data from preclinical studies of Auxora™ in acute kidney injury (AKI) at the 29th International Acute Kidney Injury and Continuous Renal Replacement Therapy Conference (AKI & CRRT) in San Diego, CA.

SK Life Science, Inc. announced an update on the use of cenobamate, an anti-seizure medication sold as XCOPRI® CV in the U.S. Data were published in Epilepsia last week providing an update on the real-world experience of the more than 100,000 unique patient exposures recently confirmed across the U.S. and the rest of the markets where cenobamate is available.

Femasys Inc. announces it will participate in a Fireside Chat with Jones Trading Analyst Catherine Novack to discuss the current treatment landscape for infertility treatment in women.

Sirona Biochem Corp announces a significant achievement in its quest to transform the skincare industry.

Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a significant update on its acquisition of Volpara Health Technologies.

Revelation Biosciences Inc. announced today new preclinical data on the potential therapeutic benefit of Gemini for the prevention of acute kidney injury (AKI) that was presented at the International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024) taking place in San Diego on March 12-15, 2024.

Rentschler Biopharma announced that the company’s U.S. subsidiary, Rentschler Biopharma Inc., has been honored with the Gold Award for the Central Massachusetts region in the 20th Annual Team Massachusetts Economic Impact Awards.

Fresenius Medical Care has announced today the appointment of Jörg Häring (54) as its new Global Head of Legal, Compliance and Human Resources.